ATE428412T1 - Behandlung von augenkrankheiten mit harnstoff und harnstoffderivaten - Google Patents

Behandlung von augenkrankheiten mit harnstoff und harnstoffderivaten

Info

Publication number
ATE428412T1
ATE428412T1 AT03709127T AT03709127T ATE428412T1 AT E428412 T1 ATE428412 T1 AT E428412T1 AT 03709127 T AT03709127 T AT 03709127T AT 03709127 T AT03709127 T AT 03709127T AT E428412 T1 ATE428412 T1 AT E428412T1
Authority
AT
Austria
Prior art keywords
urea
derivatives
treatment
compound
eye diseases
Prior art date
Application number
AT03709127T
Other languages
English (en)
Inventor
Vicken Karageozian
David Castillejos
John Park
Original Assignee
Vitreo Retinal Technologies In
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vitreo Retinal Technologies In filed Critical Vitreo Retinal Technologies In
Application granted granted Critical
Publication of ATE428412T1 publication Critical patent/ATE428412T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/10—Ophthalmic agents for accommodation disorders, e.g. myopia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Surgery (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
AT03709127T 2002-02-13 2003-02-13 Behandlung von augenkrankheiten mit harnstoff und harnstoffderivaten ATE428412T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US35734702P 2002-02-13 2002-02-13
US35757402P 2002-02-15 2002-02-15
PCT/US2003/004617 WO2003068166A2 (en) 2002-02-13 2003-02-13 Treatment of ophthalmic disorders using urea and urea derivatives

Publications (1)

Publication Number Publication Date
ATE428412T1 true ATE428412T1 (de) 2009-05-15

Family

ID=27737587

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03709127T ATE428412T1 (de) 2002-02-13 2003-02-13 Behandlung von augenkrankheiten mit harnstoff und harnstoffderivaten

Country Status (15)

Country Link
EP (1) EP1480678B1 (de)
JP (1) JP2005521681A (de)
KR (1) KR20040094687A (de)
CN (1) CN1633308A (de)
AT (1) ATE428412T1 (de)
AU (1) AU2003213084B2 (de)
BR (1) BR0307611A (de)
CA (1) CA2475338C (de)
DE (1) DE60327179D1 (de)
ES (1) ES2325360T3 (de)
IL (1) IL163374A (de)
MX (1) MXPA04007802A (de)
NZ (1) NZ535165A (de)
RU (1) RU2339369C2 (de)
WO (1) WO2003068166A2 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7977385B2 (en) 2000-03-02 2011-07-12 Numoda Biotechnologies, Inc. Agents for corneal or intrastromal administration to treat or prevent disorders of the eye
US20030199574A1 (en) 2000-03-02 2003-10-23 Vitreo-Retinal Technologies, Inc. Treatment of ophthalmic disorders using urea and urea derivatives
RU2363459C2 (ru) * 2002-03-14 2009-08-10 Витрио-Ретинол Текнолоджиз, Инк. Средства для введения в роговицу глаз или внутрь стромы для лечения или предотвращения офтальмологических нарушений
KR102509892B1 (ko) * 2016-08-18 2023-03-13 트로이 브레머 리포솜 작제물을 사용한 황반 및 망막의 세포에의 우레아의 전달
JP7089603B2 (ja) * 2018-06-11 2022-06-22 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 眼疾患を治療するための脱メチル化

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5A (en) * 1836-08-10 Thomas Blanchard Machine for mortising solid wooden shells of ships' tackle-blocks
GB8908063D0 (en) * 1989-04-11 1989-05-24 Beecham Group Plc Novel compounds
JP3610368B2 (ja) * 1993-05-27 2005-01-12 セネス リミティド 治療用置換グアニジン
US5470881A (en) * 1993-09-09 1995-11-28 West Virginia University Research Corporation Urea ophthalmic ointment and solution
WO1995014461A1 (en) * 1993-11-23 1995-06-01 Cambridge Neuroscience, Inc. Therapeutic substituted guanidines
US5441984A (en) * 1994-01-06 1995-08-15 Eli Lilly And Company Urea, thiourea and guanidine derivatives
FR2728169A1 (fr) * 1994-12-19 1996-06-21 Oreal Utilisation d'un antagoniste de substance p pour le traitement des prurits et des dysesthesies oculaires ou palpebrales
US6395758B1 (en) * 1998-08-14 2002-05-28 Gpi Nil Holdings, Inc. Small molecule carbamates or ureas for vision and memory disorders
DE60039043D1 (de) * 1999-03-02 2008-07-10 Vitreo Retinal Technologies In Mittel für intravitreale verabreichung zur behandlung oder vorbeugung von augenerkrankungen
AU763750B2 (en) * 1999-04-05 2003-07-31 City Of Hope Novel inhibitors of formation of advanced glycation endproducts (AGE's)
US6545182B2 (en) * 2000-04-13 2003-04-08 Allergan Sales, Inc. Methods and compositions for modulating alpha adrenergic receptor activity
US6313172B1 (en) * 2000-04-13 2001-11-06 Allergan Sales, Inc. Methods and compositions for modulating alpha adrenergic receptor activity

Also Published As

Publication number Publication date
WO2003068166A2 (en) 2003-08-21
WO2003068166A3 (en) 2003-12-24
DE60327179D1 (de) 2009-05-28
AU2003213084A1 (en) 2003-09-04
EP1480678A4 (de) 2005-08-24
EP1480678B1 (de) 2009-04-15
AU2003213084B2 (en) 2008-06-26
CA2475338A1 (en) 2003-08-21
RU2339369C2 (ru) 2008-11-27
CA2475338C (en) 2014-08-19
MXPA04007802A (es) 2005-04-19
EP1480678A2 (de) 2004-12-01
RU2004127610A (ru) 2005-06-27
BR0307611A (pt) 2004-12-21
JP2005521681A (ja) 2005-07-21
ES2325360T3 (es) 2009-09-02
KR20040094687A (ko) 2004-11-10
CN1633308A (zh) 2005-06-29
NZ535165A (en) 2006-08-31
IL163374A (en) 2012-01-31

Similar Documents

Publication Publication Date Title
DE60225556D1 (de) Dpp-iv-inhibierende purin-derivative zur behandlung von diabetes
ATE375341T1 (de) Thiadiazolylpiperazinderivate geeignet für die behandlung bzw. prävention von schmerzen
DE68902649D1 (de) Lokal anzuwendende arzneizubereitung zur behandlung von entzuendungserkrankungen.
DE60227658D1 (de) Verfahren zur behandlung neurodegenerativer, psychiatrischer und anderer störungen mit deacetylaseinhibitoren
DK1411932T3 (da) Kombinationsterapi med substituerede oxazolidinoner
DE602004030222D1 (de) 2-oxo-1,3,5-perhydrotriazapinderivate, die sich zur behandlung von hyperproliferativen, angiogenen und entzündlichen erkrankungen eignen
BG106825A (en) Substituted oxazolidinones and their use in the field of blood coagulation
FI962591A0 (fi) Kasvuhormonia vapauttavia ominaisuuksia sisältäviä yhdisteitä
BRPI0410029B8 (pt) composto dihidroquinazolina substituído, processo para sua preparação, medicamento compreendendo o referido composto e uso do referido composto
WO2005056524A3 (en) Therapeutic agents useful for treating pain
MXPA02012272A (es) Compuestos heterociclicos que son inhibidores de la enzima dipeptidilpeptidasa-iv.
ATE144420T1 (de) Verwendung von riluzol zur behandlung von parkinson und den parkinson-syndromen
ATE142877T1 (de) Melatoninderivate zur behandlung von schlafstörungen und zur pre-anästhesie
PT804252E (pt) Agentes queladores metalicos que contem monoaminas diamidas e tiois
MY147643A (en) Use of benzo-fused heterocycle sulfamide derivatives for the treatment of mania and bipolar disorder
ATE361918T1 (de) 4-(4-methoxybenzyl)-n&#39;-(5-nitro-1,3-thiazol-2- yl)harnstoff und dessen verwendung bei der behandlung von mit glycogensynthasekinase-3 (gsk3) assoziierten leiden
DE60327179D1 (de) Behandlung von augenkrankheiten mit harnstoff und harnstoffderivaten
DE69524780D1 (de) Verwendung von indolderivaten zur behandlung von dermatologischen krankheiten, peridhren neuropathien, arthritis, allergischen oder chronisch-obstruktiven atemwegserkrankungen, glaukom und augenentzündungen
BRPI0412131A (pt) métodos de tratamento de distúrbios oftálmicos, para evitar hemorragia retìnica, perda de acuidade visual, reduzir exsudatos duros e retardar progressão de dano retìnico
BR0317289A (pt) Método para tratar distúrbios do movimento usando derivados do ácido barbitúrico
ATE285773T1 (de) Pharmazeutische zusammensetzungen zur behandlung von neurologischen krankheiten
ATE440835T1 (de) Heterozyklische harnstoff-derivate für die behandlung von schmerzen.
BR0317714A (pt) Oxazóis como realçadores de mglur1
DE69623316D1 (de) Ctla-8 in kombination mit g-csf oder mit g-csf und il-6, und verwendung vom ctla-8 zur behandlung von infektionen
ATE359995T1 (de) Amin-1,2- und -1,3-diolverbindungen und deren verwendung zur behandlung von alzheimer-krankheit

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties